Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Weiwei Shao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2691-0542; OpenAlex author ID A5091680687. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Comprehensive comparisons of total pancreatectomy versus pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a double-center, retrospective study. Co-author DOI 10.21037/gs-2025-aw-544↗
  2. Identifying optimal candidates for tumor resection among borderline and locally advanced pancreatic cancer: A population-based predictive model. First author DOI 10.1016/j.pan.2022.01.004↗
  3. Acidic Tumor Microenvironment Promotes Pancreatic Cancer through miR-451a/MEF2D Axis. Co-author DOI 10.1155/2022/3966386↗
  4. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study. Co-author DOI 10.3389/fsurg.2021.804785↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinghai Song · 3 shared papers, 2021–2022 · strength 0.49
  2. Shaocheng Lyu · 1 shared paper, 2026 · strength 0.33
  3. Qiang He · 1 shared paper, 2026 · strength 0.33
  4. Ren Lang · 1 shared paper, 2026 · strength 0.33
  5. Zhenhua Lu · 2 shared papers, 2021–2022 · strength 0.30
  6. Jingyong Xu · 2 shared papers, 2021–2022 · strength 0.30
  7. Junmin Wei · 1 shared paper, 2022 · strength 0.19
  8. Jingyong Xu · 1 shared paper, 2022 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.